COMMUNITY HEALTH SYSTEMS INC
Close on Oct 19, 2026
- Market cap
- $376.75M
- P/E (TTM)
- 1.5
- Dividend yield
- –
About Community Health Systems
Services-General Medical & Surgical Hospitals, NEC, SIC 8062
Community Health Systems, Inc. operates healthcare delivery systems that provide inpatient and outpatient medical services to patients in local communities. Its service offerings include general acute care, emergency treatment, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostics, psychiatric care, and rehabilitation. In addition to hospital facilities, the company delivers care through outpatient access points such as physician practices, urgent care centers, freestanding emergency departments, imaging facilities, cancer centers, and ambulatory surgery centers. The company serves individual patients, and its revenues derive from payments made by government agencies, private insurance providers, and patients directly.
The company conducts operations across 36 markets in 14 states. Its subsidiaries own or lease 69 affiliated hospitals with more than 10,000 beds, and manage over 1,000 care sites. The organization employs approximately 1,700 physicians and 1,400 licensed healthcare practitioners. The provided text does not identify the company's headquarters.
Summary of the business section of Community Health Systems's latest annual report, written by StockData.
Company profile
Company
- Legal name
- COMMUNITY HEALTH SYSTEMS INC
- Founded
- 1985
- Headquarters
- Franklin, TN
- Address
- 4000 Meridian Boulevard 37067
- Phone
- (615) 465-7000
- Website
- chs.net
- Employees
- 57,000, Dec 31, 2025
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Nashville, Tennessee
Stock & identifiers
- Ticker
- CYH
- Exchange
- NYSE
- IPO date
- Jun 9, 2000
- Shares outstanding
- 141M, Jul 16, 2026
- Public float
- $415.20M, Jun 30, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1108109
- CUSIP
- 203668108
- ISIN
- US2036681086
- LEI
- 549300BQWM4WENQ3YW73
- EIN
- 13-3893191
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Tim Hingtgen | CEO, Director | 1,267,588 |
| David V. Rice | EVP-Clinical Operations & CMO | 30,000 |
| Jason K. Johnson | EVP & CFO | 202,049 |
| Kevin J. Hammons | CEO | 992,441 |
| Kevin A. Stockton | EVP, Operations & Development | 213,863 |
| Justin D. Pitt | Pres,Chief Legal&Admin Officer | 300,334 |
| Phillip A. Posey | SVP & CAO | 52,924 |
| Miguel S. Benet | President and CMO | 47,635 |
| Austen D. Mason | Regional President | 142,500 |
| Mark B. Medley | Regional President | 128,637 |
| Chad A. Campbell | Regional President | 150,787 |
| William Norris Jennings | Director | 38,468 |
| K. Ranga Krishnan | Director | 170,023 |
| Ronald L. Burgess Jr | Director | 0 |
| John A. Clerico | Director | 368,763 |
| John A. Fry | Director | 268,966 |
| Michael Dinkins | Director | 204,976 |
| Fawn D. Lopez | Director | 0 |
| James S. Ely III | Director | 377,027 |
| Wayne T. Smith | Director | 7,306,142 |
| Hubert James Williams | Director | 171,024 |
| Elizabeth T. Hirsch | Director | 142,126 |
| Joseph Arthur Hastings | Director | 17,130 |
| Susan W. Brooks | Director | 67,856 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Kevin JHammons | $4.77M | $3.91M | $2.27M | $108 | $149 |
| FY2025 Tim Hingtgen | $7.85M | -$4.99M | $2.27M | $108 | $149 |
| FY2024 | – | $7.13M | $2.42M | $103 | $132 |
| FY2024 Tim Hingtgen | $7.63M | $7.13M | $2.42M | $103 | $132 |
| FY2023 | – | $5.92M | $2.29M | $108 | $131 |
| FY2023 Tim Hingtgen | $8.35M | $5.92M | $2.29M | $108 | $131 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“At December 31, 2025, we had approximately 57,000 employees, including approximately 13,000 part-time employees.”
Corporate history
Events identified from SEC filings